Cargando…

Pan-Cancer Analysis Reveals PPRC1 as a Novel Prognostic Biomarker in Ovarian Cancer and Hepatocellular Carcinoma

Background and Objectives: As is well understood, peroxisome proliferator-activated receptor gamma cofactor-related 1 (PPRC1) plays a central role in the transcriptional control of the mitochondrial biogenesis and oxidative phosphorylation (OXPHOS) process, yet its critical role in pan-cancer remain...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruan, Xingqiu, Cui, Guoliang, Li, Changyu, Sun, Zhiguang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146118/ https://www.ncbi.nlm.nih.gov/pubmed/37109742 http://dx.doi.org/10.3390/medicina59040784

Ejemplares similares

Prognostic and immunological role of Ras-related protein Rap1b in pan-cancer
por: Cui, Guoliang, et al.
Publicado: (2021)

PPRC1, but not PGC-1α, levels directly correlate with expression of mitochondrial proteins in human dermal fibroblasts
por: Mori, Mateus Prates, et al.
Publicado: (2020)

Pan-cancer analyses reveal IGSF10 as an immunological and prognostic biomarker
por: Zhou, Yongxia, et al.
Publicado: (2023)

ARPC2: A Pan-Cancer Prognostic and Immunological Biomarker That Promotes Hepatocellular Carcinoma Cell Proliferation and Invasion
por: Huang, Shenglan, et al.
Publicado: (2022)

Pan-cancer analysis reveals potential of FAM110A as a prognostic and immunological biomarker in human cancer
por: Zhong, Hongguang, et al.
Publicado: (2023)

Pan-cancer analysis identifies ITIH1 as a novel prognostic indicator for hepatocellular carcinoma
por: Chang, Qing-hua, et al.
Publicado: (2021)

Prognostic Biomarker DDOST and Its Correlation With Immune Infiltrates in Hepatocellular Carcinoma
por: Zhu, Changyu, et al.
Publicado: (2022)

Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer
por: Chen, Buze, et al.
Publicado: (2023)

Pan-Cancer Profiling and Digital Pathology Analysis Reveal Negative Prognostic Biomarker ZPR1 Associated with Immune Infiltration and Treatment Response in Hepatocellular Carcinoma
por: He, Lian, et al.
Publicado: (2023)

IMPDH1, a prognostic biomarker and immunotherapy target that correlates with tumor immune microenvironment in pan-cancer and hepatocellular carcinoma
por: Liu, Chengdong, et al.
Publicado: (2022)

Pan-Cancer analysis shows that ACO2 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including hepatocellular carcinoma
por: Wang, Zhen, et al.
Publicado: (2022)

Ancient genes can be served as pan‐cancer diagnostic and prognostic biomarkers
por: Ji, Xiangwen, et al.
Publicado: (2020)

Comprehensive pan-cancer analysis of PTGES3 and its prognostic role in hepatocellular carcinoma
por: Wang, Han, et al.
Publicado: (2023)

PTBPs: An immunomodulatory-related prognostic biomarker in pan-cancer
por: Chen, Chen, et al.
Publicado: (2022)

Integrative Pan-Cancer Analysis Reveals Decreased Melatonergic Gene Expression in Carcinogenesis and RORA as a Prognostic Marker for Hepatocellular Carcinoma
por: Zou, Yi, et al.
Publicado: (2021)

RAMP1 as a novel prognostic biomarker in pan-cancer and osteosarcoma
por: Xie, Long, et al.
Publicado: (2023)

Prognostic, Immunological, and Mutational Analysis of MTA2 in Pan-Cancer and Drug Screening for Hepatocellular Carcinoma
por: Huang, Xueshan, et al.
Publicado: (2023)

Systematic Pan-Cancer Analysis and Experimental Verification Identify FOXA1 as an Immunological and Prognostic Biomarker in Epithelial Ovarian Cancer
por: Wang, Kai, et al.
Publicado: (2022)

Author Correction: Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer
por: Chen, Buze, et al.
Publicado: (2023)

Type V collagen alpha 1 chain promotes the malignancy of glioblastoma through PPRC1-ESM1 axis activation and extracellular matrix remodeling
por: Tsai, Hsing-Fang, et al.
Publicado: (2021)

Pan-cancer analysis suggests histocompatibility minor 13 is an unfavorable prognostic biomarker promoting cell proliferation, migration, and invasion in hepatocellular carcinoma
por: Liu, Jun, et al.
Publicado: (2022)

Pan-Cancer Analysis Reveals FH as a Potential Prognostic and Immunological Biomarker in Lung Adenocarcinoma
por: Zhang, Heng, et al.
Publicado: (2021)

RIPK4 Is an Immune Regulating-Associated Biomarker for Ovarian Cancer and Possesses Generalization Value in Pan-Cancer
por: Liao, Cui, et al.
Publicado: (2022)

DNTTIP1 is a Prognostic Biomarker Correlated With Immune Infiltrates in Hepatocellular Carcinoma: A Study Based on The Cancer Genome Atlas Data
por: Zhu, Changyu, et al.
Publicado: (2022)

FAM65A as a novel prognostic biomarker in human tumors reveal by a pan-cancer analysis
por: Liang, Wenken, et al.
Publicado: (2021)

Systematic Pan-Cancer Analysis Reveals X-C Motif Chemokine Receptor 1 as a Prognostic and Immunological Biomarker
por: Cui, Likun, et al.
Publicado: (2023)

Pan-cancer analysis of the prognostic and immunological role of ANLN: An onco-immunological biomarker
por: Liu, Kejun, et al.
Publicado: (2022)

Pan-cancer and single-cell analysis reveals FAM83D expression as a cancer prognostic biomarker
por: Yu, Haiyang, et al.
Publicado: (2022)

BRCA1-Associated Protein Is a Potential Prognostic Biomarker and Is Correlated With Immune Infiltration in Liver Hepatocellular Carcinoma: A Pan-Cancer Analysis
por: Ju, Qiang, et al.
Publicado: (2020)

Pan-cancer analysis identifies FAM49B as an immune-related prognostic maker for hepatocellular carcinoma
por: Xu, Feng, et al.
Publicado: (2022)

The Prognostic and Immunotherapeutic Significance of AHSA1 in Pan-Cancer, and Its Relationship With the Proliferation and Metastasis of Hepatocellular Carcinoma
por: Li, Wenli, et al.
Publicado: (2022)

Arylsulfatase I is a prognostic biomarker for head and neck squamous cell carcinoma and Pan‐cancer
por: Shen, Yiming, et al.
Publicado: (2022)

Pan-cancer analysis of aldolase B gene as a novel prognostic biomarker for human cancers
por: Zhao, Nannan, et al.
Publicado: (2023)

Comprehensive analysis of pan‐cancer reveals potential of ASF1B as a prognostic and immunological biomarker
por: Hu, Xinyao, et al.
Publicado: (2021)

Pan-cancer analysis reveals NUP37 as a prognostic biomarker correlated with the immunosuppressive microenvironment in glioma
por: He, Ya, et al.
Publicado: (2022)

Identification of novel prognostic biomarkers in the TF-enhancer-target regulatory network in hepatocellular carcinoma and immune infiltration analysis
por: Yan, Jianing, et al.
Publicado: (2023)

A pan-cancer analysis reveals CHD1L as a prognostic and immunological biomarker in several human cancers
por: Soltan, Mohamed A., et al.
Publicado: (2023)

Pan-cancer analysis reveals that G6PD is a prognostic biomarker and therapeutic target for a variety of cancers
por: Zeng, Tao, et al.
Publicado: (2023)

Pan-cancer analysis and single-cell analysis revealed the role of ABCC5 transporter in hepatocellular carcinoma
por: Chen, Liang, et al.
Publicado: (2021)

An Integrative Analysis Revealing ZFHX4-AS1 as a Novel Prognostic Biomarker Correlated with Immune Infiltrates in Ovarian Cancer
por: Huang, Changchang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5556huh0076e798rfnn0madifp